Overcoming Cognitive and Residual Symptoms In Major Depression: Enhancing Patient Outcomes in the Primary Care Setting
WebcastFaculty
OVERVIEW
Overcoming Cognitive and Residual Symptoms In Major Depression: Enhancing Patient Outcomes in the Primary Care Setting is organized by National Association for Continuing Education (NACE) and will be held during Feb 02, 2017 - Feb 01, 2018.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
This monograph will provide information about the need for understanding and recognizing Depression. Case studies will be presented throughout the monograph which will highlight that disturbances in mood, sleep and concentration are the most common presenting and residual symptoms of depression. Strategies to reduce/minimize side effects will be discussed in addition to the relationship between depression, cognition and treatment options.
Pharmacologic therapies will be reviewed highlighting that avoiding the 5HT-2 receptor to minimize sexual dysfunction; and understanding what receptors are targeted by specific antidepressants to maximize benefit while minimizing side to improve patient outcomes. Emphasis is placed on improved communication with the patient regarding utilization of medications for relief of depression and anxiety as well as the need for appropriate referral as needed.
Conference Objectives are:
• Recognize the overlap of emotional, physical and cognitive challenges in patients with major depressive disorder (MDD)
• Explore the impact of residual symptoms and cognitive dysfunction on optimal patient outcomes
• Develop strategies in the primary care setting to minimize long term side effect burden in an effort to increase adherence to MDD treatment
• Discuss newly approved treatment options for MDD while exploring their role in residual cognitive symptoms, selective side effect profile and remission of depressive symptoms
Additional details will be posted as soon as they are available.
The target audience for this medical event is Primary Care Providers. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits.
Conference Description:
This monograph will provide information about the need for understanding and recognizing Depression. Case studies will be presented throughout the monograph which will highlight that disturbances in mood, sleep and concentration are the most common presenting and residual symptoms of depression. Strategies to reduce/minimize side effects will be discussed in addition to the relationship between depression, cognition and treatment options.
Pharmacologic therapies will be reviewed highlighting that avoiding the 5HT-2 receptor to minimize sexual dysfunction; and understanding what receptors are targeted by specific antidepressants to maximize benefit while minimizing side to improve patient outcomes. Emphasis is placed on improved communication with the patient regarding utilization of medications for relief of depression and anxiety as well as the need for appropriate referral as needed.
Conference Objectives are:
• Recognize the overlap of emotional, physical and cognitive challenges in patients with major depressive disorder (MDD)
• Explore the impact of residual symptoms and cognitive dysfunction on optimal patient outcomes
• Develop strategies in the primary care setting to minimize long term side effect burden in an effort to increase adherence to MDD treatment
• Discuss newly approved treatment options for MDD while exploring their role in residual cognitive symptoms, selective side effect profile and remission of depressive symptoms
Additional details will be posted as soon as they are available.
SPECIALITIES
Psychiatry
Quick Links